Abstract
The intention of this review is to emphasize the current knowledge about the extent and importance of the substances co-localized with magnocellular arginine vasopressin (AVP) and oxytocin (OXY) as potential candidates for the gradual clarification of their actual role in the regulation of hydromineral homeostasis. Maintenance of the body hydromineral balance depends on the coordinated action of principal biologically active compounds, AVP and OXY, synthesized in the hypothalamic supraoptic and paraventricular nuclei. However, on the regulation of water–salt balance, other substances, co-localized with the principal neuropetides, participate. These can be classified as (1) peptides co-localized with AVP or OXY with unambiguous osmotic function, including angiotensin II, apelin, corticotropin releasing hormone, and galanin and (2) peptides co-localized with AVP or OXY with an unknown role in osmotic regulation, including cholecystokinin, chromogranin/secretogranin, dynorphin, endothelin-1, enkephalin, ferritin protein, interleukin 6, kininogen, neurokinin B, neuropeptide Y, vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, TAFA5 protein, thyrotropin releasing hormone, tyrosine hydroxylase, and urocortin. In this brief review, also the responses of these substances to different hyperosmotic and hypoosmotic challenges are pointed out. Based on the literature data published recently, the functional implication of the majority of co-localized substances is still better understood in non-osmotic than osmotic functional circuits. Brattleboro strain of rats that does not express functional vasopressin was also included in this review. These animals suffer from chronic hypernatremia and hyperosmolality, accompanied by sustained increase in OXY mRNA in PVN and SON and OXY levels in plasma. They represent an important model of animals with constantly sustained osmolality, which in the future, will be utilizable for revealing the physiological importance of biologically active substances co-expressed with AVP and OXY, involved in the regulation of plasma osmolality.
Similar content being viewed by others
References
Abramova M, Calas A, Thibault J, Ugrumov M (2000) Tyrosine hydroxylase in vasopressinergic axons of the pituitary posterior lobe of rats under salt loading as a manifestation of neurochemical plasticity. Neural Plast 7:179–191. doi:10.1155/NP.2000.179
Aguilera G (1998) Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab 9:329–336. doi:10.1016/S1043-2760(98)00079-4
Almeida TA, Rojo J, Nieto PM, Pinto FM, Hernandez M, Martin JD et al (2004) Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 11:2045–2081
Ang CW, Dotman CH, Winkler H, Fischer-Colbrie R, Sonnesmans MA, Van Leeuwen FW (1997) Specific expression of secretogranin II in magnocellular vasopressin neurons of the rat supraoptic and paraventricular nucleus in response to osmotic stimulation. Brain Res 765:13–20. doi:10.1016/S0006-8993(97)00462-9
Anita I, Yaira M, María del Rosario G (2006) Endothelin signaling pathways in rat adrenal medulla. Cell Mol Neurobiol 26:703–718. doi:10.1007/s10571-006-9111-3
Arima H, Aguilera G (2000) Vasopressinergic and oxytocinergic neurons of supraoptic and paraventricular nuclei co-express mRNA for type-1 and type-2 corticotropin releasing hormone receptors. J Neuroendocrinol 12:833–842. doi:10.1046/j.1365-2826.2000.00528.x
Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48:301–331. doi:10.2170/jjphysiol.48.301
Armstrong WE (1995) Morphological and electrophysiological classification of hypothalamic supraoptic neurons. Prog Neurobiol 47:291–339. doi:10.1016/0301-0082(95)00025-9
Armstrong WE (2004) Hypothalamic supraoptic and paraventricular nuclei. In: The rat nervous system, 3rd edn. (Paxinos G. ed.) Elsevier, USA, pp 369–388
Bacova Z, Kiss A, Jamal B, Payer J Jr, Strbak V (2006) Effect of swelling on TRH and oxytocin secretion from hypothalamic structures. Cell Mol Neurobiol 26:1045–1053. doi:10.1007/s10571-006-9013-4
Baigent SM (2001) Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22:809–820. doi:10.1016/S0196-9781(01)00395-3
Baile CA, Della-Fera MA, McLaughlin CL (1983) Hormones and feed intake. Proc Nutr Soc 42:113–127. doi:10.1079/PNS19830018
Balment RJ, Brimble MJ, Forsling ML (1980) Release of oxytocin induced by salt loading and its influence on renal excretion in the male rat. J Physiol 308:439–449
Bardrum B, Ottesen B, Fahrenkrug J, Fuchs A-R (1988) Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide. Endocrinology 123:2249–2254
Beck B, Max JP (2007) Hypothalamic galanin and plasma leptin and ghrelin in the maintenance of energy intake in the Brattleboro rat. Biochem Biophys Res Commun 364:60–65. doi:10.1016/j.bbrc.2007.09.092
Bodnar RJ, Klein GE (2005) Endogenous opiates and behavior. Peptides 26:2629–2711. doi:10.1016/j.peptides.2005.06.010
Brailoiu GC, Dun SL, Yang J, Ohsawa M, Chang JK, Dun NJ (2002) Apelin immunoreactivity in the rat hypothalamus and pituitary. Neurosci Lett 327:193–197. doi:10.1016/S0304-3940(02)00411-1
Brimble MJ, Balment RJ, Smith CP, Windle RJ, Forsling ML (1991) Influence of oxytocin on sodium excretion in the anaesthetized Brattleboro rat. J Endocrinol 129:49–54
Bruhn TO, Sutton SW, Plotsky PM, Vale WW (1986) Central administration of corticotropin-releasing factor modulates oxytocin secretion in the rat. Endocrinology 119:1558–1563
Burazin TCD, Larm JA, Gundlach AL (2001) Regulation by osmotic stimuli of galanin-R1 receptor expression in magnocelular neurones of the paraventricular and supraoptic nuclei of the rat. J Neuroendocrinol 13:358–370. doi:10.1046/j.1365-2826.2001.00640.x
Carter DA, Vallejo M, Lightman SL (1985) Cardiovascular effects of neuropeptide Y in the nucleus tractus solitarius of rats: relationship with noradrenaline and vasopressin. Peptides 6:421–425. doi:10.1016/0196-9781(85)90107-X
Ceccatelli S, Fahrenkrug J, Villar MJ, Hökfelt T (1991) Vasoactive intestinal polypeptide/peptide histidine isoleucine immunoreactive neuron systems in the basal hypothalamus of the rat with special reference to the portal vasculature: an immunohistochemical and in situ hybridization study. Neuroscience 43:483–502. doi:10.1016/0306-4522(91)90310-K
Chahl LA (2006) Tachykinins and neuropsychiatric disorders. Curr Drug Targets 7:993–1003. doi:10.2174/138945006778019309
Chandra R, Liddle RA (2007) Cholecystokinin. Curr Opin Endocrinol Diabetes Obes 14:63–67
Chen D, Assad-Kottner C, Orrego C, Torre-Amione G (2008a) Cytokines and acute heart failure. Crit Care Med 36:S9–S16
Chen JX, Tang YT, Yang JX (2008b) Changes of glucocorticoid receptor and levels of CRF mRNA, POMC mRNA in brain of chronic immobilization stress rats. Cell Mol Neurobiol 28:237–244. doi:10.1007/s10571-007-9170-0
Ciosek J, Stempniak B (1995) Thyrotropin-releasing hormone (TRH) modifies oxytocin release from the hypothalamo-neurohypophysial system in salt loaded rats. J Physiol Pharmacol 46:169–177
Cisowska-Maciejewska A, Ciosek J (2005) Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats. J Physiol Pharmacol 56:673–688
Cox BM, Ghazarossian VE, Goldstein A (1980) Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neurosci Lett 20:85–88. doi:10.1016/0304-3940(80)90238-4
Crawley JN (1999) The role of galanin in feeding behavior. Neuropeptides 33:369–375. doi:10.1054/npep.1999.0049
Cummings S, Elde R, Ells J, Lindall A (1983) Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3:1355–1368
da Silveira LT, Junta CM, Monesi N, De Oliveira-Pelegrin GR, Passos GA, Rocha MJ (2007) Time course of c-fos, vasopressin and oxytocin mRNA expression in the hypothalamus following long-term dehydration. Cell Mol Neurobiol 27:284–575. doi:10.1007/s10571-007-9144-2
Day NC, Hall MD, Hughes J (1989) Modulation of hypothalamic cholecystokinin receptor density with changes in magnocellular activity: a quantitative autoradiographic study. Neuroscience 29:371–383. doi:10.1016/0306-4522(89)90064-X
de Stahl TD, Hartmann C, De Bustos C, Piotrowski A, Benetkiewicz M, Mantripragada KK et al (2005) Chromosome 22 tiling-path array-CGH analysis identifies germ-line- and tumor-specific aberrations in patients with glioblastoma multiforme. Genes Chromosomes Cancer 44:161–169. doi:10.1002/gcc.20226
Dohanics J, Kovacs KJ, Makara GB (1990) Oxytocinergic neurons in rat hypothalamus. Dexamethasone-reversible increase in their corticotropin-releasing factor-41-like immunoreactivity in the response to osmotic stimulation. Neuroendocrinology 51:515–522. doi:10.1159/000125385
Dores RM, Lecaudé S, Bauer D, Danielson PB (2002) Analyzing the evolution of the opioid/orphanin gene family. Mass Spectrom Rev 21:220–243. doi:10.1002/mas.10029
Drolet G, Dumont EC, Gosselin I, Kinkead R, Laforest S, Trottier JF (2001) Role of endogenous opioid system in the regulation of the stress response. Prog Neuropsychopharmacol Biol Psychiatry 25:729–741. doi:10.1016/S0278-5846(01)00161-0
Edwards BR, LaRochelle FT Jr (1984) Antidiuretic effect of endogenous oxytocin in dehydrated Brattleboro homozygous rats. Am J Physiol 247:F453–F465
Falcao-Pires I, Leite-Moreira AF (2005) Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 24:1263–1276
Gaymann W, Martin R (1989) Immunoreactive galanin-like material in magnocellular hypothalamo-neurohypophysial neurones of the rat. Cell Tissue Res 255:139–147. doi:10.1007/BF00229075
Gerdes HH, Phillips E, Huttner WB (1988) The primary structure of rat secretogranin II deduced from a cDNA sequence. Nucleic Acids Res 16:11811. doi:10.1093/nar/16.24.11811
Ghorbel MT, Sharman G, Leroux M, Barrett T, Donovan DM, Becker KG et al (2003) Microarray analysis reveals interleukin-6 as a novel secretory product of the hypothalamo-neurohyphyseal system. J Biol Chem 278:19280–19285. doi:10.1074/jbc.M209902200
Gillard ER, León-Olea M, Mucio-Ramírez S, Coburn CG, Sánchez-Islas E, De Leon A et al (2006) A novel role for endogenous pituitary adenylate cyclase activating polypeptide in the magnocellular neuroendocrine system. Endocrinology 147:791–803. doi:10.1210/en.2005-1103
Gimpl G, Fahrenholz F (2001) The oxytocin receptor system: structure, function, and regulation. Physiol Rev 81:629–683
Giovannelli L, Shiromani PJ, Jirikowski GF, Bloom FE (1990) Oxytocin neurons in the rat hypothalamus exhibit c-fos immunoreactivity upon osmotic stress. Brain Res 531:299–303. doi:10.1016/0006-8993(90)90789-E
Glazova MV, Krasnovskaia IA (1996) The effect of thyroliberin on the nonapeptidergic hypothalamo-hypophyseal neurosecretory system in rats (in-vivo and in-vitro research). Fiziol Zh Im I M Sechenova 82:65–69
Gottlieb HB, Ji LL, Jones H, Penny ML, Fleming T, Cunningham JT (2006) Differential effects of water and saline intake on water deprivation-induced c-fos staining in the rat. Am J Physiol Regul Integr Comp Physiol 290:1251–1261. doi:10.1152/ajpregu.00727.2005
Guldenaar SE, Noctor SC, McCabe JT (1992) Fos-like immunoreactivity in the brain of homozygous diabetes insipidus Brattleboro and normal Long-Evans rats. J Comp Neurol 322:439–448. doi:10.1002/cne.903220310
Haanwinckel MA, Elias LK, Favaretto AL, Gutkowska J, McCann SM, Antunes RJ (1995) Oxytocin mediates atrial natiuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 92:7096–7902. doi:10.1073/pnas.92.17.7902
Hara Y, Ueta Y, Isse T, Kabashima N, Shibuya I, Hattori Y et al (1997a) Increase of urocortin-like immunoreactivity in the rat hypothalamo-neurohypophysial system after salt loading and hypophysectomy. Neurosci Lett 227:127–130. doi:10.1016/S0304-3940(97)00327-3
Hara Y, Ueta Y, Isse T, Kabashima N, Shibuya I, Hattori Y et al (1997b) Increase of urocortin-like immunoreactivity in the rat supraoptic nucleus after dehydration but not food deprivation. Neurosci Lett 229:65–68. doi:10.1016/S0304-3940(97)00419-9
Harding JW, Jensen LL, Hanesworth JM, Roberts KA, Page TA, Wright JW (1992) Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. Am J Physiol 262:F17–F23
Hatae T, Kawano H, Karpitskiy V, Krause JE, Masuko S (2001a) Arginine-vasopressin neurons in the rat hypothalamus produce neurokinin B and co-express the tachykinin NK-3 receptor and angiotensin II type 1 receptor. Arch Histol Cytol 64:37–44. doi:10.1679/aohc.64.37
Hatae T, Nakayama Y, Kawano H, Masuko S (2001b) Effects of water deprivation on neurokinin B production by the arginine-vasopressin neurons of hypothalamic paraventricular and supraoptic nuclei. Fukuoka Igaku Zasshi 92:89–98
Hatakeyama S, Kawai Y, Ueyama T, Senba E (1996) Nitric oxide synthase-containing magnocellular neurons of the rat hypothalamus synthesize oxytocin and vasopressin and express fos following stress stimuli. J Chem Neuroanat 11:243–256. doi:10.1016/S0891-0618(96)00166-4
Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED et al (2005) Pathobiology of dynorphins in trauma and disease. Front Biosci 10:216–235. doi:10.2741/1522
Hawkins RL, Printz MP (1983) Distribution of angiotensinogen in Brattleboro rat brain. Brain Res Bull 10:163–166. doi:10.1016/0361-9230(83)90089-8
Hinks GL, Poat JA, Hughes J (1995) Changes in hypothalamic cholecystokininA and cholecystokininB receptor subtypes and associated neuropeptide expression in response to salt stress in the rat and mouse. Neuroscience 68:765–781. doi:10.1016/0306-4522(95)00148-C
Hoene M, Weigert C (2008) The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. Obes Rev 9:20–29
Hooi SC, Richardson GS, McDonald JK, Allen JM, Martin JB, Koening JI (1989) Neuropeptide Y (NPY) and vasopressin (AVP) in the hypothalamo-neurohypophysial axis of salt loaded or Brattleboro rats. Brain Res 486:214–220. doi:10.1016/0006-8993(89)90507-6
Hou Yu A, Lamme AT, Zimmerman EA, Silverman AJ (1986) Comparative distribution of vasopressin and oxytocin neurons in the rat brain using a double-label procedure. Neuroendocrinology 44:235–246. doi:10.1159/000124651
Hoysoya Y, Matsushita M (1979) Identification and distribution of the spinal and hypophysial projection neurons in the apraventricular nucleus of the rat: a light and electron microscopic study with the horseradish peroxidase method. Exp Brain Res 35:315–332
Huttner WB, Gerdes HH, Rosa P (1991) The granin (chromogranin/secretogranin) family. Trends Biochem Sci 16:27–30. doi:10.1016/0968-0004(91)90012-K
Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S (2001) Expression of corticotropin releasing factor (CRF), urocortine and CRF type 1 receptors in hypotalamic-hypophyseal systems under osmotic stimulation. J Neuroendocrinol 13:328–338. doi:10.1046/j.1365-2826.2001.00629.x
Imboden H, Felix D (1991) An immunocytochemical comparison of the angiotensin and vasopressin hypothalamo-neurohypophysial systems in normotensive rats. Regul Pept 36:197–218. doi:10.1016/0167-0115(91)90057-N
Israel A, Plunkett L, Saavedra JM (1986) Increased number of angiotensin II binding sites determined by autoradiography in anterior pituitary of water-deprived and Brattleboro rats. Neuroendocrinology 42:57–63. doi:10.1159/000124249
Jankovic BD, Radulovic J (1992) Enkephalins, brain and immunity: modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 67:241–270
Jessop D, Sidhu R, Lightman SL (1990) Osmotic regulation of methionine enkephalin in the posterior pituitary of the rat. Brain Res 516:41–45. doi:10.1016/0006-8993(90)90895-I
Johnson AK, Thunhorst RL (1997) The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration. Front Neuroendocrinol 18:292–353. doi:10.1006/frne.1997.0153
Kagotani Y, Hisano S, Tsuruo Y, Daikoku S, Chihara K (1990) Vasopressin-deficient paraventricular magnocellular neurons of homozygous Brattleboro rats synthesize neuropeptide Y. Neurosci Lett 112:37–42. doi:10.1016/0304-3940(90)90318-4
Kakiya S, Yokoi H, Arima H, Iwasaki Y, Oki Y, Oiso Y (1998) Central administration of urocortin inhibits vasopressin release in conscious rats. Neurosci Lett 248:144–146. doi:10.1016/S0304-3940(98)00357-7
Katoh T, Chang H, Uchida S, Okuda T, Kurokawa K (1990) Direct effects of endothelin in the rat kidney. Am J Physiol 258:F397–F402
Kiss JZ, Mezey E (1986) Tyrosine hydroxylase in magnocellular neurosecretory neurons response to physiological manipulations. Neuroendocrinology 43:519–525. doi:10.1159/000124576
Kiss A, Mikkelsen JD (2005) Oxytocin—anatomy and functional assignments: a minireview. Endocr Regul 39:97–105
Kjaer A, Knigge U, Bach FW, Warberg J (1993) Impaired histamine- and stress-induced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats. Neuroendocrinology 57:1035–1041. doi:10.1159/000126468
Koenig JI, Hooi S, Gabriel SM, Martin JB (1989) Potential involvement of galanin in the regulation of fluid homeostasis in the rat. Regul Pept 24:81–86. doi:10.1016/0167-0115(89)90213-9
Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259–263
Kozuka M, Ito T, Hirose S, Takahashi K, Hagiwara H (1989) Endothelin induces two types of contractions of rat uterus: phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channels. Biochem Biophys Res Commun 159:317–323. doi:10.1016/0006-291X(89)92440-6
Lang R, Gundlach AL, Kofler B (2007) The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther 115:177–207. doi:10.1016/j.pharmthera.2007.05.009
Larsen PJ, Jukes KE, Chowdrey HS, Lightman SL, Jessop DS (1994) Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology 134:1635–1639. doi:10.1210/en.134.4.1635
Larsen PJ, Mikkelsen JD (1992) Vasoactive intestinal peptide (VIP) in magnocellular neurons of the hypothalamo-neurohypophysial system of the mink (Mustela vision) is co-localized with vasopressin or oxytocin. J Comp Neurol 326:180–192. doi:10.1002/cne.903260203
Larsen PJ, Sheikh SP, Mikkelsen JD (1992) Osmotic regulation of neuropeptide Y and its binding sites in the magnocellular hypothalamo-neurohypophysial pathway. Brain Res 573:181–189. doi:10.1016/0006-8993(92)90761-W
Laulin JP, Simonnet G, Brudieux R, Carayon A, Vincent JD (1988) A ldosterone secretion and adrenal angiotensin II receptors in Brattleboro rat. J Endocrinol 117:215–221
Leng G, Brown CH, Russell JA (1999) Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 57:625–655. doi:10.1016/S0301-0082(98)00072-0
Lind RW, Swanson LW, Bruhn TO, Ganten D (1985a) The distribution of angiotensin II-immunoreactive cells and fibers in the paraventriculo-hypophysial system of the rat. Brain Res 338:81–89. doi:10.1016/0006-8993(85)90250-1
Lind RW, Swanson LW, Ganten D (1985b) Organization of angiotensin II immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. Neuroendocrinology 40:2–24. doi:10.1159/000124046
Liu H, Hökfelt T (2002) The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci 23:468–474. doi:10.1016/S0165-6147(02)02074-6
Liu S, Ju G (1994) Origin of CCK-like immunoreactive nerve fibers in the neurohypophysis of the rat. Brain Res 651:7–15. doi:10.1016/0006-8993(94)90675-0
Llorens-Cortés C, Beaudet A (2005) Apelin, a neuropeptide that counteracts vasopressin secretion. Med Sci (Paris) 21:741–746
Llorens-Cortes C, Moos F (2008) Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin, and vasopressin in maintaining body-fluid homeostasis. Prog Brain Res 170:559–570. doi:10.1016/S0079-6123(08)00443-3
Lukiw WJ (2006) Endogenous signaling complexity in neuropeptides-leucine and methionine-enkephalin. Cell Mol Neurobiol 26:1003–1010. doi:10.1007/s10571-006-9100-6
Ma D, Morris JF (2002) Protein synthetic machinery in the dendrites of the magnocellular neurosecretory neurons of wild-type Long-Evans and homozygous Brattleboro rats. J Chem Neuroanat 23:171–186. doi:10.1016/S0891-0618(01)00158-2
Mahata K, Mahata M, Hörtnagl H, Fischer-Colbrie R, Steiner HJ, Dietze O et al (1993) Concomitant changes of messenger ribonucleic acid levels of secretogranin II, VGF, vasopressin and oxytocin in the paraventricular nucleus of rats after adrenalectomy and during lactation. J Neuroendocrinol 5:323–330. doi:10.1111/j.1365-2826.1993.tb00489.x
Mahata SK, Mahata M, Steiner HJ, Fischer-Colbrie R, Winkler H (1992) In situ hybridization: mRNA levels of secretogranin II, neuropeptides and carboxypeptidase H in brains of salt loaded and Brattleboro rats. Neuroscience 48:669–680. doi:10.1016/0306-4522(92)90410-4
Marsais F, Parmentier C, Terao E, Taxi J, Calas A (2002) Expression of tyrosine hydroxylase and vasopressin in magnocellular neurons of salt loaded aged rats. Microsc Res Tech 56:81–91. doi:10.1002/jemt.10018
Martin R, Voigt KH (1981) Enkephalins co-exist with oxytocin and vasopressin in nerve terminals of rat neurohypophysis. Nature 289:502–504. doi:10.1038/289502a0
McDonald MP, Gleason TC, Robinson JK, Crawley JN (1998) Galanin inhibits performance on rodent memory tasks. Ann NY Acad Sci 863:305–322. doi:10.1111/j.1749-6632.1998.tb10704.x
Meister B, Cortés R, Villar MJ, Schalling M, Hökfelt T (1990a) Peptides and transmitter enzymes in hypothalamic magnocellular neurons after administration of hyperosmotic stimuli: comparison between messenger RNA and peptide/protein levels. Cell Tissue Res 260:279–297. doi:10.1007/BF00318631
Meister B, Villar MJ, Ceccatelli S, Hökfelt T (1990b) Localization of chemical messengers in magnocellular neurons of the hypothalamic supraoptic and paraventricular nuclei: an immunohistochemical study using experimental manipulations. Neuroscience 37:603–633. doi:10.1016/0306-4522(90)90094-K
Micevych PE, Park SS, Akesson TR, Elde R (1987) Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat: I. Hypothalamus. J Comp Neurol 255:124–136. doi:10.1002/cne.902550110
Mikkelsen JD (1989) Immunohistochemical localization of vasoactive intestinal peptide (VIP) in the circumventricular organs of the rat. Cell Tissue Res 255:307–3013. doi:10.1007/BF00224113
Mikkelsen JD, Møller M (1988) Vasoactive intestinal peptide in the hypothalamohypophysial system of the Mongolian gerbil. J Comp Neurol 273:87–98. doi:10.1002/cne.902730108
Mlynarik M, Zelena D, Bagdy G, Makara GB, Jezova D (2007) Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats. Horm Behav 51:395–405. doi:10.1016/j.yhbeh.2006.12.007
Nakamura S, Naruse M, Naruse K, Shioda S, Nakai Y, Uemura H (1993) Colocalization of immunoreactive endothelin-1 and neurohypophysial hormones in the axons of the neural lobe of the rat pituitary. Endocrinology 132:530–533. doi:10.1210/en.132.2.530
Nakata M, Kohno D, Shintani N, Nemoto Y, Hashimoto H, Baba A et al (2004) PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci Lett 370:252–256. doi:10.1016/j.neulet.2004.08.034
Namer B, Hilliges M, Orstavik K, Schmidt R, Weidner C, Torebjörk E et al (2007) Endothelin1 activates and sensitizes human C-nociceptors. Pain 137(1):41–49
Nomura M, Ueta Y, Serino R, Kabashima N, Shibuya I, Yamashita H (1996) PACAP type I receptor gene expression in the paraventricular and supraoptic nuclei of rats. Neuroreport 8:67–70. doi:10.1097/00001756-199612200-00014
Nomura M, Ueta Y, Serino R, Yamamoto Y, Shibuya I, Yamashita H (1999) Effects of centrally administered pituitary adenylate cyclase-activating polypeptide on c-fos gene expression and heteronuclear RNA for vasopressin in rat paraventricular and supraoptic nuclei. Neuroendocrinology 69:167–180. doi:10.1159/000054416
O’Shea RD, Gundlach AL (1996) Food or water deprivation modulate nitric oxide synthase (NOS) activity and gene expression in rat hypothalamic neurones: correlation with neurosecretory activity? J Neuroendocrinol 8:417–425. doi:10.1046/j.1365-2826.1996.04682.x
Orino K, Lehman L, Tsuji Y, Ayaki H, Torti SV, Torti FM (2001) Ferritin and the response to oxidative stress. Biochem J 357:241–247. doi:10.1042/0264-6021:3570241
Panayotacopoulou MT, Raadsheer FC, Swaab DF (1994) Colocalization of tyrosine hydroxylase with oxytocin or vasopressin in neurons of the human paraventricular and supraoptic nucleus. Brain Res Dev Brain Res 83:59–66. doi:10.1016/0165-3806(94)90179-1
Paulsen SJ, Christensen MT, Vrang N, Larsen LK (2008) The putative neuropeptide TAFA5 is expressed in the hypothalamic paraventricular nucleus and is regulated by dehydration. Brain Res 1199:1–9. doi:10.1016/j.brainres.2007.12.074
Phillips MI (1987) Functions of angiotensin in the central nervous system. Annu Rev Physiol 49:413–435. doi:10.1146/annurev.ph.49.030187.002213
Reaux A, De Mota N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M, Llorens-Cortés C (2001) Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77:1085–1096. doi:10.1046/j.1471-4159.2001.00320.x
Reaux-Le Goazigo A, Morinville A, Burlet A, Llorens-Cortés C, Beaudet A (2004) Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145:4392–4400. doi:10.1210/en.2004-0384
Recalcati S, Invernizzi P, Arosio P, Cairo G (2008) New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30:84–89. doi:10.1016/j.jaut.2007.11.003
Richoux JP, Gelly JL, Bouhnik J, Baussant T, Alhene-Gelas F, Grignon G et al (1991) The kallikrein–kinin system in the rat hypothalamus. Immunohistochemical localization of high molecular weight kininogen and T-kininogen in different neuronal systems. Histochemistry 96:229–243. doi:10.1007/BF00271541
Rökaeus Å, Young WSIII, Mezey E (1988) Galanin coexists with vasopressin in the normal rat hypothalamus and galanin’s synthesis is increased in the Brattleboro (diabetes insipidus) rat. Neurosci Lett 90:45–50. doi:10.1016/0304-3940(88)90784-7
Rossmanith WG, Clifton DK, Steiner RA (1996) Galanin gene expression in hypothalamic GnRH-containing neurons of the rat: a model for autocrine regulation. Horm Metab Res 28:257–266
Saul GBII, Garrity EB, Benirschke K, Valtin H (1968) Inherited hypothalamic diabetes insipidus in the Brattleboro strain of rats. J Hered 59:113–117
Schlosser SF, Almeida OF, Patchev VK, Yassoiridis A, Elands J (1994) Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology 135:2058–2063. doi:10.1210/en.135.5.2058
Shen PJ, Gundlach AL (1996) Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments including seizures, osmotic stimulation and axotomy in the rat. Eur J Neurosci 8:988–1000. doi:10.1111/j.1460-9568.1996.tb01586.x
Sherin JE, Elmquist JK, Torrealba F, Saper CB (1998) Innervation of histaminergic tuberomammillary neurons by GABAergic and galaninergic neurons in the ventrolateral preoptic nucleus of the rat. J Neurosci 18:4705–4721
Sherman TG, Day R, Civelli O, Douglass J, Herbert E, Akil H et al (1988) Regulation of hypothalamic magnocellular neuropeptides and their mRNAs in the Brattleboro rat: coordinate responses to further osmotic challenge. J Neurosci 8:3785–3796
Skofitsch G, Jacobowitz DM (1986) Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides 7:609–613. doi:10.1016/0196-9781(86)90035-5
Smith BN, Armstrong WE (1990) Tuberal supraoptic neurons. I. Morphological and electrophysiological characteristics observed with intracellular recording and biocytin filling in vitro. Neuroscience 38:469–483. doi:10.1016/0306-4522(90)90043-4
Smith AP, Lee NM (1988) Pharmacology of dynorphin. Annu Rev Pharmacol Toxicol 28:123–140. doi:10.1146/annurev.pa.28.040188.001011
Snyder SH (2004) Opiate receptors and beyond: 30 years of neural signaling research. Neuropharmacology 47:274–285. doi:10.1016/j.neuropharm.2004.06.006
Swanson LW, Kuypers HGJM (1980) The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and the organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling method. J Comp Neurol 194:555–570. doi:10.1002/cne.901940306
Telleria-Diaz A, Grinevich VV, Jirikowski GF (2001) Colocalization of vasopressin and oxytocin in hypothalamic magnocellular neurons in water-deprived rats. Neuropeptides 35:162–167. doi:10.1054/npep.2001.0859
Tokunaga A, Ono K, Ono T, Ogawa M (1992) Magnocellular neurosecretory neurons with ferritin-like immunoreactivity in the hypothalamic supraoptic and paraventricular nuclei of the rat. Brain Res 597:170–175. doi:10.1016/0006-8993(92)91522-G
Treschan TA, Peters J (2006) The vasopressin system: physiology and clinical strategies. Anesthesiology 105:444–445. doi:10.1097/00000542-200609000-00026
Turnbull AV, Rivier C (1997) Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein and related peptides. Proc Soc Exp Biol Med 215:1–10
Uemura H, Naruse M, Nakamura S, Naruse K, Yamamoto T, Demura H et al (1994) Immunoreactive endothelin-1 in the neural lobe of the rat pituitary following hemorrhage and dehydration. Endocr J 41:685–691
Urban JH, Leitermann RJ, Dejoseph MR, Somponpun SJ, Wolak ML, Sladek CD (2006) Influence of dehydration on the expression of neuropeptide Y Y1 receptors in hypothalamic magnocellular neurons. Endocrinology 147:4122–4131. doi:10.1210/en.2006-0377
Valtin H, Schroeder HA, Bernischke K, Sokol HW (1962) Familial hypothalamic diabetes insipidus in rats. Nature 196:1109–1110. doi:10.1038/1961109a0
Vanderhaeghen JJ, Lotstra F, Vandesande F, Dierickx K (1981) Coexistence of cholecystokinin and oxytocin-neurophysin in some magnocellular hypothalamo-hypophyseal neurons. Cell Tissue Res 221:227–231. doi:10.1007/BF00216585
Vandesande F, Dierickx K (1976) Immuno-cytochemical demonstration of the inability of the homozygous Brattleboro rat to synthesize vasopressin and vasopressin-associated neurophysin. Cell Tissue Res 165:307–316. doi:10.1007/BF00222435
Vaughan J, Donaldson C, Bittencourt J, Perrin M, Lewis K, Sutton S et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and corticotrophin-releasing factor. Nature 378:287–292. doi:10.1038/378287a0
Verbalis JG, Dohanics J (1991) Vasopressin and oxytocin secretion in chronically hyposmolar rats. Am J Physiol Regul Integr Comp Physiol 261:R1028–R1038
Wall KM, Ferguson AV (1992) Endothelin acts at the subfornical organ to influence the activity of putative vasopressin and oxytocin-secreting neurons. Brain Res 586:111–116. doi:10.1016/0006-8993(92)91378-R
Walsh DA, Mc F, Williams D (2006) Tachykinins and the cardiovascular system. Curr Drug Targets 7:1031–1042. doi:10.2174/138945006778019291
Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G et al (1982) Dynorphin and vasopressin: common localization in magnocellular neurons. Science 216:85–87. doi:10.1126/science.6121376
Weihe E, Depboylu C, Schütz B, Schäfer MK, Eiden LE (2006) Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol Neurobiol 26:659–678. doi:10.1007/s10571-006-9053-9
Wiegand SJ, Price JL (1980) Cells of origin of the afferent fibers to the median eminence in the rat. J Comp Neurol 192:1–19. doi:10.1002/cne.901920102
Xapelli S, Agasse F, Ferreira R, Silva AP, Malva JO (2006) Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide. Recent Patents CNS Drug Discov 1:315–324
Yamamoto Y, Ueta Y, Nomura M, Serino R, Kabashima N, Shibuya I et al (1997) Upregulation of neuronal NOS mRNA in the PVN and SON of inherited diabetes insipidus rats. Neuroreport 8:3907–3911
Yamauchi A, Dohgu S, Nishioku T, Shuto H, Naito M, Tsuruo T et al (2007) An inhibitory role of nitric oxide in the dynamic regulation of the blood–brain barrier function. Cell Mol Neurobiol 27:263–270. doi:10.1007/s10571-007-9139-z
You SA, Wang Q (2005) Ferritin in atherosclerosis. Clin Chim Acta 357:1–16. doi:10.1016/j.cccn.2005.02.001
Young SF, Griffante C, Aguilera G (2007) Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors. Cell Mol Neurobiol 27:439–461. doi:10.1007/s10571-006-9135-8
Young WSIII, Warden M, Mezey E (1987) Tyrosine hydroxylase mRNA is increased by hyperosmotic stimuli in the paraventricular and supraoptic nuclei. Neuroendocrinology 46:439–444. doi:10.1159/000124858
Yue C, Mutsuga N, Verbalis J, Gainer H (2006) Microarray analysis of gene expression in the supraoptic nucleus of normoosmotic and hypoosmotic rats. Cell Mol Neurobiol 26:959–978. doi:10.1007/s10571-006-9017-0
Zhang B, Glasgow E, Murase T, Verbalis JG, Gainer H (2001) Chronic hypoosmolality induces a selective decrease in magnocellular neurone soma and nuclear size in the rat hypothalamic supraoptic nucleus. J Neuroendocrinol 13:29–36. doi:10.1046/j.1365-2826.2001.00593.x
Zudenigo D, Lackovic Z (1989) Vasoactive intestinal polypeptide: a potential neurotransmitter. Lijec Vjesn 111:349–354
Acknowledgments
This work was supported by Vega 2/7003/27, CE SAS CENDO, and APVV-0148-06 grants.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bundzikova, J., Pirnik, Z., Zelena, D. et al. Response of Substances Co-Expressed in Hypothalamic Magnocellular Neurons to Osmotic Challenges in Normal and Brattleboro Rats. Cell Mol Neurobiol 28, 1033–1047 (2008). https://doi.org/10.1007/s10571-008-9306-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-008-9306-x